Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Pharma needs to embrace social media

Paul Tunnah
Meds
October 28, 2012
193 Shares
Share
Tweet
Share

Anyone working in the pharma industry will know it has been a tough few years. Dwindling innovation in the drug pipelines, the impact of global economic pressures and an increasing global focus on healthcare cost containment have all combined in a perfect storm for the sector often regarded as recession-proof.

As the backdrop to all this, social media has rapidly been finding its place as a powerful media in sectors selling directly to consumers. However, pharma has been slow to embrace the charms of blogging, online communities and popular channels such as Twitter and Facebook. The tight regulatory environment within which pharma operates is often blamed, as direct-to-consumer (patient) promotion is banned in many markets and any patient feedback must be closely monitored for drug safety information.

In reality, these are not valid arguments against social media when the benefits are considered. Here are three pivotal reasons why pharma must embrace social media.

1. PR – better relationships with doctors, patients and the public. The pharma industry does not have a great reputation. It may have kept low while the bankers have taken the flak, but recent publications such as Ben Goldacre’s Bad Pharma reveal the ongoing mistrust of the industry from medical professionals and patients. In being reluctant to socialise with such groups and explain its business in more detail, pharma is leaving the door wide open to an unbalanced and one-sided view of the way it operates.

Social media is a poor channel for direct sales in most industries, but it is a great channel for building brand trust and procuring customer feedback, both of which are well within the regulations. Developing drugs takes years of effort and significant investment – all of which means nothing to a patient who cannot afford high priced products or a doctor who does not trust the clinical data. More open communication and engagement by pharma through social media would lead to a better understanding of its business processes, greater trust and more balanced conversations about drug positioning and pricing.

2. Medication compliance – taking drugs as they were intended. Compliance, the issue of whether patients take their medicine as intended (or at all), is a critical issue for healthcare systems in general. Failure to take medicines in the right way generally leads to increased financial burden on the system further down the line as the patient’s disease worsens and medicines are branded as ineffective, which reduces sales for pharma.

Poor compliance is not just about forgetting to take medicines; it can often be caused by a failure to properly understand drug side effects (‘adverse events’ as pharma calls them), as medical product information is not easily understood by the patient and often not explained in detail by the doctor.

Better reporting of side effects and general compliance issues through social media engagement will help pharma address these issues and understand how its products are being used outside the lab. If compliance is improved it is a win-win-win for healthcare systems, the patients and pharma.

3. Patient-reported outcomes – real world evidence for medicines. The clinical trial populations used in drug development do not exactly represent the patient population in the real world. Such trials often involve younger participants with a lower incidence of associated diseases in order to provide a purer assessment of drug effectiveness.

As with compliance, understanding the post-approval impact of medicines in real life has therefore become critical to healthcare providers and pharma companies, who invest significantly in ‘phase IV’ studies. The information derived from such studies includes patient-reported outcomes (PROs) – the patient’s view on whether the medicine is helping treat the disease and has manageable side effects.

This kind of information is being shared every day in online disease-centric communities, such as PatientsLikeMe, and pharma can quickly collect this information through social channels allowing it to adapt drug positioning or target patient populations, as required.

In summary, the information pharma needs to adapt and thrive is out there right now. It just needs to embrace social media by listening, engaging and acting on it.

Paul Tunnah is founder and managing director of pharmaphorum.  This article originally appeared at Management Thinking. 

Prev

When you do the right thing, you become a better doctor

October 28, 2012 Kevin 0
…
Next

Improve doctor visits by bringing checklists to check ups

October 28, 2012 Kevin 2
…

Tagged as: Facebook, Medications, Twitter

Post navigation

< Previous Post
When you do the right thing, you become a better doctor
Next Post >
Improve doctor visits by bringing checklists to check ups

More in Meds

  • 13.1 million missing Americans since 1980. Where’s the outrage?

    Steve Burgess, MD
  • Ketamine for mental health conditions: What every primary care physician needs to know

    Carlene MacMillan, MD & L. Alison McInnes, MD
  • Learn to be a Narcan hero: a comic tutorial

    Emily Watters, MD
  • The preference for insurance coverage of opioids over non-pharmaceutical options explained

    Amy Baxter, MD
  • A comic reveals the terrifying truth about fentanyl

    Emily Watters, MD
  • The importance of physician education regarding psilocybin therapy

    Lynn Marie Morski, MD, JD
  • Most Popular

  • Past Week

    • I’m a doctor, and I almost died during childbirth

      Bayo Curry-Winchell, MD | Physician
    • Unveiling excessive medical billing and greed

      Amol Saxena, DPM, MPH | Policy
    • Bitcoin’s role in diversified portfolios [PODCAST]

      The Podcast by KevinMD | Podcast
    • Dying is a selfish business

      Nancie Wiseman Attwater | Conditions
    • Navigating medical decision-making: Embracing limits and growth

      Benjamin Wade Frush, MD | Physician
    • Empathy and compassion in palliative care [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Medical gaslighting: a growing challenge in today’s medical landscape

      Tami Burdick | Conditions
    • Balancing opioid medication in chronic pain

      L. Joseph Parker, MD | Conditions
    • I want to be a doctor who can provide care for women: What states must I rule out for my medical education?

      Nandini Erodula | Education
    • Navigating the broken medical system: challenges faced by foreign medical graduates

      Anonymous | Physician
    • Mourning the silent epidemic: the physician suicide crisis and suggestions for change

      Amna Shabbir, MD | Physician
    • The essence of medicine: genuine connections in practice

      Jennifer Tillman, MD | Physician
  • Recent Posts

    • Bitcoin’s role in diversified portfolios [PODCAST]

      The Podcast by KevinMD | Podcast
    • 1 in 5 doctors will become disabled. Are you prepared?

      Amarish Dave, DO | Finance
    • The pros and cons of whole life insurance for high-income earners

      Shane Tenny, CFP | Finance
    • Family support is pivotal in the treatment of schizophrenia

      Frank Chen, MD | Conditions
    • Is emergency medicine your calling? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Exploring disfigurement and self-worth

      Kathleen Watt | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • CDC Advisors Endorse Maternal RSV Vax to Protect Newborns
  • Amoxicillin Alone for Acute Sinusitis Holds Up Against Broad-Spectrum Cousin
  • Despite Taboo, Med Students, Doctors Use Substances Too
  • White House Opens Gun Violence Prevention Office
  • Nurses Step Up to Bat on Educating Patients About Climate Change

Meeting Coverage

  • Loneliness Needs to Be Treated Like Any Other Health Condition, Researcher Suggests
  • Stopping Medical Misinformation Requires Early Detection
  • AI Has an Image Problem in Healthcare, Expert Says
  • Want Better Health Outcomes? Check Out What Other Countries Do
  • ERS Roundup: Cell Transplant Boosts Lung Function in COPD Patients
  • Most Popular

  • Past Week

    • I’m a doctor, and I almost died during childbirth

      Bayo Curry-Winchell, MD | Physician
    • Unveiling excessive medical billing and greed

      Amol Saxena, DPM, MPH | Policy
    • Bitcoin’s role in diversified portfolios [PODCAST]

      The Podcast by KevinMD | Podcast
    • Dying is a selfish business

      Nancie Wiseman Attwater | Conditions
    • Navigating medical decision-making: Embracing limits and growth

      Benjamin Wade Frush, MD | Physician
    • Empathy and compassion in palliative care [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Medical gaslighting: a growing challenge in today’s medical landscape

      Tami Burdick | Conditions
    • Balancing opioid medication in chronic pain

      L. Joseph Parker, MD | Conditions
    • I want to be a doctor who can provide care for women: What states must I rule out for my medical education?

      Nandini Erodula | Education
    • Navigating the broken medical system: challenges faced by foreign medical graduates

      Anonymous | Physician
    • Mourning the silent epidemic: the physician suicide crisis and suggestions for change

      Amna Shabbir, MD | Physician
    • The essence of medicine: genuine connections in practice

      Jennifer Tillman, MD | Physician
  • Recent Posts

    • Bitcoin’s role in diversified portfolios [PODCAST]

      The Podcast by KevinMD | Podcast
    • 1 in 5 doctors will become disabled. Are you prepared?

      Amarish Dave, DO | Finance
    • The pros and cons of whole life insurance for high-income earners

      Shane Tenny, CFP | Finance
    • Family support is pivotal in the treatment of schizophrenia

      Frank Chen, MD | Conditions
    • Is emergency medicine your calling? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Exploring disfigurement and self-worth

      Kathleen Watt | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Pharma needs to embrace social media
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...